KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Other Non-Current Liabilities: 2009-2024

Historic Other Non-Current Liabilities for Novavax (NVAX) over the last 15 years, with Dec 2024 value amounting to $359.6 million.

  • Novavax's Other Non-Current Liabilities fell 17.38% to $263.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $263.5 million, marking a year-over-year decrease of 17.38%. This contributed to the annual value of $359.6 million for FY2024, which is 985.46% up from last year.
  • Per Novavax's latest filing, its Other Non-Current Liabilities stood at $359.6 million for FY2024, which was up 985.46% from $33.1 million recorded in FY2023.
  • In the past 5 years, Novavax's Other Non-Current Liabilities ranged from a high of $359.6 million in FY2024 and a low of $13.5 million during FY2020.
  • Over the past 3 years, Novavax's median Other Non-Current Liabilities value was $55.7 million (recorded in 2022), while the average stood at $149.5 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first slumped by 40.52% in 2023, then soared by 985.46% in 2024.
  • Over the past 5 years, Novavax's Other Non-Current Liabilities (Yearly) stood at $13.5 million in 2020, then skyrocketed by 212.47% to $42.1 million in 2021, then spiked by 32.23% to $55.7 million in 2022, then slumped by 40.52% to $33.1 million in 2023, then skyrocketed by 985.46% to $359.6 million in 2024.